TrialJournal of cancer research and clinical oncology2025

Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanoma.

Jonathan S Zager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.